News

California-based ICU Medical failed to submit proper documents for significant changes to two devices made in Minneapolis, ...
About the Artificial Dye Ban. On April 22, the FDA issued a statement saying it will phase out all petroleum-based synthetic ...
The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with diabetes.
The FDA plans to phase out petroleum-based food dyes, aiming to protect public health—especially children—as part of the ...
BD (NYSE: BDX) announced today that it received FDA 510(k) clearance for its Phasix ST umbilical hernia patch.
Pfizer’s anti-TFPI antibody marstacimab has been approved by the FDA to treat haemophilia, becoming the pharma group’s second new therapy for the blood disorder this year. Marstacimab will be ...